AN EVALUATION OF PROGNOSTIC SCORING SYSTEMS IN PATIENTS WITH FOLLICULAR THYROID-CANCER

被引:32
作者
DAVIS, NL
BUGIS, SP
MCGREGOR, GI
GERMANN, E
机构
[1] VANCOUVER HOSP & HLTH SCI CTR,VANCOUVER,BC,CANADA
[2] BRITISH COLUMBIA CANC AGCY,VANCOUVER,BC V5Z 4E6,CANADA
关键词
D O I
10.1016/S0002-9610(99)80333-X
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: prognostic scoring systems for thyroid cancer have not been investigated in patients with pure follicular cancer; thus, the purpose of this study was to compare the following prognostic indices: the European Organization for Research and Treatment of Cancer (EORTC) method; the Age, Grade, Extent, Size (AGES). score; and the Age, Metastasis, Extent, Size (AMES) score. PATIENTS AND METHODS: A retrospective study reviewing 122 patients actively treated between 1955 and 1990 was conducted. Scoring systems were calculated and survival analysis completed. AGES low-risk patients were analyzed with respect to known risk factors. RESULTS: The AGES scoring system significantly defined low- and high-risk groups (P = 0.0041); the ratio of deaths between high-versus tow-risk groups was 1.9:1. EORTC scores distinguished four risk groups (P = 0.002). The AMES scoring system did not significantly assign risk. In multivariate analysis of low-risk AGES patients, age, perithyroidal tissue involvement, and positive frozen section reached statistical significance. CONCLUSIONS: The AGES and EORTC scoring systems best defined low- and high-risk groups of patients with pure follicular cancer, although the separation between groups was low.
引用
收藏
页码:476 / 480
页数:5
相关论文
共 14 条
[1]   FOLLICULAR THYROID-CANCER TREATED AT THE MAYO-CLINIC, 1946 THROUGH 1970 - INITIAL MANIFESTATIONS, PATHOLOGICAL FINDINGS, THERAPY, AND OUTCOME [J].
BRENNAN, MD ;
BERGSTRALH, EJ ;
VANHEERDEN, JA ;
MCCONAHEY, WM .
MAYO CLINIC PROCEEDINGS, 1991, 66 (01) :11-22
[2]   PROGNOSTIC INDEX FOR THYROID-CARCINOMA - STUDY OF THE EORTC-THYROID-CANCER-COOPERATIVE-GROUP [J].
BYAR, DP ;
GREEN, SB ;
DOR, P ;
WILLIAMS, ED ;
COLON, J ;
VANGILSE, HA ;
MAYER, M ;
SYLVESTER, RJ ;
VANGLABBEKE, M .
EUROPEAN JOURNAL OF CANCER, 1979, 15 (08) :1033-1041
[3]  
CADY B, 1988, SURGERY, V104, P947
[4]   SURVIVAL DISCRIMINANTS FOR DIFFERENTIATED THYROID-CANCER [J].
CUNNINGHAM, MP ;
DUDA, RB ;
RECANT, W ;
CHMIEL, JS ;
SYLVESTER, J ;
FREMGEN, A .
AMERICAN JOURNAL OF SURGERY, 1990, 160 (04) :344-347
[5]  
DONOHUE JH, 1984, AM J SURG, V148, P168, DOI 10.1016/0002-9610(84)90306-4
[6]  
EMERICK GT, 1993, CANCER, V72, P3287, DOI 10.1002/1097-0142(19931201)72:11<3287::AID-CNCR2820721126>3.0.CO
[7]  
2-5
[8]   DEATHS DUE TO DIFFERENTIATED THYROID-CANCER - A 46-YEAR PERSPECTIVE [J].
HARNESS, JK ;
MCLEOD, MK ;
THOMPSON, NW ;
NOBLE, WC ;
BURNEY, RE .
WORLD JOURNAL OF SURGERY, 1988, 12 (05) :623-629
[9]  
HAY I, 1987, SURGERY, V102, P1171
[10]   PAPILLARY THYROID-CARCINOMA [J].
HAY, ID .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1990, 19 (03) :545-576